These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7851106)

  • 1. Moricizine and quality of life in the Cardiac Arrhythmia Suppression Trial II (CAST II).
    Brooks MM; Gorkin L; Schron EB; Wiklund I; Campion J; Ledingham RB
    Control Clin Trials; 1994 Dec; 15(6):437-49. PubMed ID: 7851106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
    Anderson JL; Platia EV; Hallstrom A; Henthorn RW; Buckingham TA; Carlson MD; Carson PE
    Circulation; 1994 Dec; 90(6):2843-52. PubMed ID: 7994829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
    Greene HL; Roden DM; Katz RJ; Woosley RL; Salerno DM; Henthorn RW
    J Am Coll Cardiol; 1992 Apr; 19(5):894-8. PubMed ID: 1552108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
    Cardiac Arrhythmia Suppression Trial II Investigators
    N Engl J Med; 1992 Jul; 327(4):227-33. PubMed ID: 1377359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ventricular arrhythmias after CAST.
    Tonkin AM
    Med J Aust; 1992 Apr; 156(7):488-92. PubMed ID: 1372950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
    Epstein AE; Hallstrom AP; Rogers WJ; Liebson PR; Seals AA; Anderson JL; Cohen JD; Capone RJ; Wyse DG
    JAMA; 1993 Nov; 270(20):2451-5. PubMed ID: 8230622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moricizine hydrochloride (Ethmozine).
    Dunn SL
    Crit Care Nurse; 1992 Apr; 12(4):61-3. PubMed ID: 1568380
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
    Akiyama T; Pawitan Y; Campbell WB; Papa L; Barker AH; Rubbert P; Friedman L; Keller M; Josephson RA
    J Am Geriatr Soc; 1992 Jul; 40(7):666-72. PubMed ID: 1607582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
    Peters RW; Mitchell LB; Brooks MM; Echt DS; Barker AH; Capone R; Liebson PR; Greene HL
    J Am Coll Cardiol; 1994 Feb; 23(2):283-9. PubMed ID: 8294678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moricizine: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP
    Am J Med Sci; 1991 Jun; 301(6):398-401. PubMed ID: 2039027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moricizine for cardiac arrhythmias.
    Med Lett Drugs Ther; 1990 Nov; 32(830):99-100. PubMed ID: 2233510
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between ease of suppression of ventricular arrhythmia and survival.
    Goldstein S; Brooks MM; Ledingham R; Kennedy HL; Epstein AE; Pawitan Y; Bigger JT
    Circulation; 1995 Jan; 91(1):79-83. PubMed ID: 7805221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
    Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; Quiñones M; Lown B
    Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAST II stopped after deaths.
    Br J Hosp Med; 1991 Nov; 46(5):345. PubMed ID: 1958941
    [No Abstract]   [Full Text] [Related]  

  • 15. Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST).
    Willund I; Gorkin L; Pawitan Y; Schron E; Schoenberger J; Jared LL; Shumaker S
    Qual Life Res; 1992 Jun; 1(3):187-201. PubMed ID: 1301128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1).
    Gorkin L; Schron EB; Brooks MM; Wiklund I; Kellen J; Verter J; Schoenberger JA; Pawitan Y; Morris M; Shumaker S
    Am J Cardiol; 1993 Feb; 71(4):263-7. PubMed ID: 8427165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crime, misdemeanor, and arrhythmia decoding CAST.
    Kerin NZ
    J Clin Pharmacol; 1991 Nov; 31(11):1044-52. PubMed ID: 1753008
    [No Abstract]   [Full Text] [Related]  

  • 18. Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients.
    Giardina EG; Wechsler ME; Dolgopiatova M; Sciacca R
    J Clin Pharmacol; 1994 Jul; 34(7):725-33. PubMed ID: 7523457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) Investigators
    Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC; Ettinger A; Todd L; Brezsnyak ML; Campion J; McBride R; Thomas S; Corum J; Schron E
    Am J Crit Care; 1996 Jan; 5(1):19-25. PubMed ID: 8680488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.